HYBIO PHARMACEUTIC revenue breakdown overview

HYBIO PHARMACEUTIC revenue for the last year amounted to 590.00 M CNY, the most of which — 259.90 M CNY — came from its highest performing source at the moment, Active Pharmaceutical Ingredient, the year earlier bringing 121.38 M CNY. The greatest contribution to the revenue figure was made by Foreign — last year it brought HYBIO PHARMACEUTIC 325.18 M CNY, and the year before that — 112.21 M CNY.